AR120727A1 - Composición farmacéutica que comprende bpi-7711 y método de preparación de la misma - Google Patents
Composición farmacéutica que comprende bpi-7711 y método de preparación de la mismaInfo
- Publication number
- AR120727A1 AR120727A1 ARP200103449A ARP200103449A AR120727A1 AR 120727 A1 AR120727 A1 AR 120727A1 AR P200103449 A ARP200103449 A AR P200103449A AR P200103449 A ARP200103449 A AR P200103449A AR 120727 A1 AR120727 A1 AR 120727A1
- Authority
- AR
- Argentina
- Prior art keywords
- pharmaceutical composition
- preparation
- same
- bpi
- comprises bpi
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911264353.1A CN110898026A (zh) | 2019-12-11 | 2019-12-11 | 包含bpi-7711的药用组合物及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR120727A1 true AR120727A1 (es) | 2022-03-09 |
Family
ID=69824307
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP200103449A AR120727A1 (es) | 2019-12-11 | 2020-12-11 | Composición farmacéutica que comprende bpi-7711 y método de preparación de la misma |
Country Status (4)
Country | Link |
---|---|
CN (1) | CN110898026A (zh) |
AR (1) | AR120727A1 (zh) |
TW (1) | TW202122087A (zh) |
WO (1) | WO2021115425A1 (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110898026A (zh) * | 2019-12-11 | 2020-03-24 | 倍而达药业(苏州)有限公司 | 包含bpi-7711的药用组合物及其制备方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105085489B (zh) * | 2014-11-05 | 2019-03-01 | 益方生物科技(上海)有限公司 | 嘧啶或吡啶类化合物、其制备方法和医药用途 |
EA201892661A1 (ru) * | 2016-06-17 | 2019-07-31 | Бета Фарма, Инк. | Фармацевтические соли n-(2-(2-(диметиламино)этокси)-4-метокси-5-((4-(1-метил-1h-индол-3-ил)пиримидин-2-ил)амино)фенил)акриламида и их кристаллические формы |
MX2019015177A (es) * | 2017-06-16 | 2020-02-07 | Beta Pharma Inc | Formulaciones farmaceuticas de n-(2-(2-(dimetilamino)etoxi)-4-meto xi-5((4-(1-metil-1h-indol-3-il)pirimidin-2-il)amino)fenil)acrilam ida y las sales de ellas. |
CN110898026A (zh) * | 2019-12-11 | 2020-03-24 | 倍而达药业(苏州)有限公司 | 包含bpi-7711的药用组合物及其制备方法 |
-
2019
- 2019-12-11 CN CN201911264353.1A patent/CN110898026A/zh active Pending
-
2020
- 2020-12-11 TW TW109143982A patent/TW202122087A/zh unknown
- 2020-12-11 WO PCT/CN2020/135660 patent/WO2021115425A1/zh active Application Filing
- 2020-12-11 AR ARP200103449A patent/AR120727A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
TW202122087A (zh) | 2021-06-16 |
WO2021115425A1 (zh) | 2021-06-17 |
CN110898026A (zh) | 2020-03-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JOP20220155A1 (ar) | مشتقات البيرازول مفيدة كعوامل مضادة للسرطان | |
MX2020000268A (es) | Agonista de fxr. | |
PH12018502227A1 (en) | Macrocyclic mcl1 inhibitors for treating cancer | |
MX2022008066A (es) | Compuestos triciclicos sustituidos. | |
MX2022006475A (es) | Compuestos triciclicos sustituidos. | |
MX2021012756A (es) | Derivado de un anillo inhibidor de btk, metodo de preparacion de este y aplicacion farmaceutica para este. | |
EA201201496A1 (ru) | Способ ингибирования интегразы вич, способ улучшения фармакокинетики 6-(3-хлор-2-фторбензил)-1-[(2s)-1-гидрокси-3-метилбутан-2-ил]-7-метокси-4-оксо-1,4-дигидрохинолин-3-карбоновой кислоты (варианты), набор, фармацевтическая композиция (варианты) и антиретровирусный агент (варианты) | |
MX2020002696A (es) | Compuestos de bisamida que activan el sarcomero y sus usos. | |
MX2022001784A (es) | Piperidinil-metil-purinaminas como inhibidores de nsd2 y antineoplásicos. | |
DOP2024000039A (es) | Derivados de quinolina como inhibidores de la integrina alfa4beta7 | |
MX2017012295A (es) | Derivados formilados n-heterociclicos como inhibidores de fgfr4. | |
MA48798B1 (fr) | Procédé de production d'ozanimod | |
NZ749427A (en) | Thiophene, manufacturing method thereof, and pharmaceutical application of same | |
MX2022004451A (es) | Heteroaril-bifenil-amidas para el tratamiento de enfermedades relacionadas con el ligando pd-l1. | |
AU2020288567A8 (en) | Pyrrolopyrimidine compound and use thereof | |
MX2021003662A (es) | Derivado de aminonorbornano y metodo de fabricacion del mismo y uso del mismo. | |
MX2022005615A (es) | Derivado triciclico de dihidroimidazopirimidona, metodo de preparacion del mismo, composicion farmaceutica y uso del mismo. | |
TN2016000491A1 (en) | Carboxamide derivatives. | |
MX2022004450A (es) | Aminas de heteroaril-bifenilo para el tratamiento de enfermedades pd-l1. | |
MX2021012105A (es) | Compuestos de pirrol. | |
WO2020016847A3 (en) | Purification process for preparation of eribulin and intermediates thereof | |
PH12019500618A1 (en) | Pharmaceutical composition and method for treatment of non-alcoholic fatty liver disease | |
EA201891682A1 (ru) | Производное азациклического амида, способ его получения и фармацевтическое применение | |
AR120727A1 (es) | Composición farmacéutica que comprende bpi-7711 y método de preparación de la misma | |
CO2022008616A2 (es) | Composición farmacéutica oral que comprende compuesto de carbamato y método de preparación para la misma |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |